LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.77 | 21.74 | 969 | 2602 | 0.3723 | 0.7333 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.77 | 21.74 | 994 | 2602 | 0.3819 | 0.7397 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.77 | 21.74 | 84 | 2602 | 0.0323 | 0.2163 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 35.77 | 21.74 | 1051 | 2602 | 0.4038 | 0.7538 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 37.74 | 21.74 | 991 | 2828 | 0.3504 | 0.7226 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 37.74 | 21.74 | 1010 | 2828 | 0.3571 | 0.7273 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 37.74 | 21.74 | 105 | 2828 | 0.0371 | 0.2514 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 37.74 | 21.74 | 1054 | 2828 | 0.3727 | 0.7378 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 39.71 | 21.74 | 1012 | 3084 | 0.3281 | 0.7113 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 39.71 | 21.74 | 1033 | 3084 | 0.3349 | 0.7162 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 39.71 | 21.74 | 109 | 3084 | 0.0353 | 0.2530 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 39.71 | 21.74 | 1076 | 3084 | 0.3489 | 0.7261 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.68 | 21.74 | 1027 | 3418 | 0.3004 | 0.6961 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.68 | 21.74 | 1054 | 3418 | 0.3083 | 0.7022 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.68 | 21.74 | 128 | 3418 | 0.0374 | 0.2750 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.68 | 21.74 | 1096 | 3418 | 0.3206 | 0.7113 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.65 | 21.74 | 1049 | 3754 | 0.2794 | 0.6847 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.65 | 21.74 | 1073 | 3754 | 0.2858 | 0.6898 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.65 | 21.74 | 134 | 3754 | 0.0357 | 0.2773 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.65 | 21.74 | 1120 | 3754 | 0.2983 | 0.6996 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.62 | 21.74 | 1086 | 4150 | 0.2616 | 0.6756 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.62 | 21.74 | 1104 | 4150 | 0.2660 | 0.6793 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.62 | 21.74 | 147 | 4150 | 0.0354 | 0.2869 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.62 | 21.74 | 1132 | 4150 | 0.2727 | 0.6848 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.59 | 21.74 | 1108 | 4492 | 0.2467 | 0.6672 | MN20160310_N01 | D08 |